Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David García is active.

Publication


Featured researches published by David García.


Archives of Biochemistry and Biophysics | 2009

Studies on the functional significance of a C-terminal S-shaped motif in human arginase type I: essentiality for cooperative effects.

David García; Elena Uribe; Marcela Lobos; María S. Orellana; Nelson Carvajal

The functional significance of a C-terminal S-shaped motif (residues 304-322) in human arginase I was explored by examining the kinetic properties of the R308A mutant and truncated species terminating in either Arg-308 or Ala-308. Replacement of Arg-308 with alanine, with or without truncation, yielded monomeric species. All mutants were kinetically indistinguishable from the wild-type enzyme at the optimum pH of 9.5. At the more physiological, pH 7.5, hyperbolic kinetics was observed for all the mutants, in contrast with the cooperative behavior exhibited by the wild-type species. In the presence of 2mM guanidinium chloride (Gdn(+)), the single mutant R308A changed to a trimeric and kinetically cooperative form, whereas the other enzyme variants were not altered. The S-shaped motif is suggested as essential for the cooperative response of the enzyme to l-arginine at pH 7.5. Gdn(+) is suggested to mimic the guanidine group of Arg-308 at the monomer-monomer interface.


Journal of Inorganic Biochemistry | 2015

Insight on the interaction of an agmatinase-like protein with Mn2 + activator ions

Matías Quiñones; Jaime Cofré; José Benítez; David García; Nicol Romero; Arlette González; Nelson Carvajal; María de los Angeles García; Vasthi López; Gerhard Schenk; Elena Uribe

Agmatinase is an enzyme that catalyzes the hydrolysis of agmatine, a compound that is associated with numerous functions in the brain of mammalian organisms such as neurotransmitter, anticonvulsant, antinociceptive, anxiolytic and antidepressant-like actions. To date the only characterized agmatinases with significant enzymatic activity were extracted from bacterial organisms. These agmatinases are closely related to another ureahydrolase, arginase; both have binuclear Mn(2+) centers in their active sites. An agmatinase-like protein (ALP) from rat brain was identified that bears no sequence homology to known agmatinases (E. Uribe, M. Salas, S. Enriquez, M.S. Orellana, N. Carvajal, Arch. Biochem. Biophys. 461(2007) 146-150). Since all known ureahydrolases contain histidines in their binuclear Mn(2+) site each of the five histidine residues in ALP was individually replaced by alanines to identify those that may be involved in metal ion binding. Reactivation assays and thermal stability measurements indicated that His206 is likely to interact with a Mn(2+) bound to a high affinity site. In contrast, His65 and possibly His435 are important for binding of a second Mn(2+) to a lower affinity site. Metal ion binding to that site is not only leading to an increase in reactivity but also enzyme stability. Thus, similar to bacterial agmatinases and some of the antibiotic-degrading, Zn(2+)-dependent metallo-β-lactamases ALP appears to be active in the mono and binuclear form, with binding of the second metal ion increasing both reactivity and stability.


Journal of Inorganic Biochemistry | 2014

Further insight into the inhibitory action of a LIM/double zinc-finger motif of an agmatinase-like protein.

Jaime Cofré; Paola Montes; Alejandro Vallejos; José Benítez; David García; José Martínez-Oyanedel; Nelson Carvajal; Elena Uribe

Agmatine is a precursor for polyamine biosynthesis also associated to neurotransmitter, anticonvulsant, antineurotoxic and antidepressant actions in the brain. It results from decarboxylation of l-arginine by arginine decarboxylase and it is hydrolyzed to urea and putrescine by agmatinase. Recently, we have described a new protein which also hydrolyzes agmatine although its sequence greatly differs from all known agmatinases. This agmatinase-like protein (ALP) contains a LIM-like double Zn-finger domain close to its carboxyl terminus, whose removal results in a truncated variant with a 10-fold increased kcat, and a 3-fold decreased Km value for agmatine. Our proposal was that the LIM-domain functions as an autoinhibitory, regulatory entity for ALP. Results in this report provide additional support for the postulated inhibitory effect. The purified isolated LIM domain was shown to be competitively inhibitory to a truncated variant ALP (lacking the LIM-domain), but not to the wild-type species. The C453A variant was shown to be a Zn(2+)-free enzyme with kinetic parameters similar to those of the truncated-ALP. A molecular dynamic simulation of a modeled LIM-domain 3D structure showed that, as a consequence of C453A mutation, the coordination of the zinc ion is broken and the structure of the zinc finger is melted. The inhibitory action of the LIM/double Zinc-finger motif was associated to a significant conformational change, as detected by tryptophan fluorescence studies, but was not related to changes in the association of the enzyme with the catalytically essential Mn(2+).


Journal of Inorganic Biochemistry | 2017

Mammalian agmatinases constitute unusual members in the family of Mn2 +-dependent ureahydrolases

Nicol Romero; José Benítez; David García; Arlette González; Leonardo Bennun; María García-Robles; Vasthi López; Liam A. Wilson; Gerhard Schenk; Nelson Carvajal; Elena Uribe

Agmatine (1-amino-4-guanidinobutane) plays an important role in a range of metabolic functions, in particular in the brain. Agmatinases (AGMs) are enzymes capable of converting agmatine to the polyamine putrescine and urea. AGMs belong to the family of Mn2+-dependent ureahydrolases. However, no AGM from a mammalian source has yet been extracted in catalytically active form. While in human AGM the six amino acid ligands that coordinate the two Mn2+ ions in the active site are conserved, four mutations are observed in the murine enzyme. Here, we demonstrate that similar to its human counterpart murine AGM does not appear to have in vitro catalytic activity, independent of the presence of Mn2+. However, in presence of agmatine both enzymes are very efficient in promoting cell growth of a yeast strain that is deficient in polyamine biosynthesis (Saccharomyces cerevisiae strain TRY104Δspe1). Furthermore, mutations among the putative Mn2+ binding residues had no effect on the ability of murine AGM to promote growth of the yeast culture. It thus appears that mammalian AGMs form a distinct group within the family of ureahydrolases that (i) either fold in a manner distinct from other members in this family, or (ii) require accessory proteins to bind Mn2+ in a mechanism related to that observed for the Ni2+-dependent urease.


Metabolism-clinical and Experimental | 2018

Metabolic strategies for the degradation of the neuromodulator agmatine in mammals

José Benítez; David García; Nicol Romero; Arlette González; José Martínez-Oyanedel; Maximiliano Figueroa; Mónica Salas; Vasthi López; María García-Robles; P. R. Dodd; Gerhard Schenk; Nelson Carvajal; Elena Uribe

Agmatine (1-amino-4-guanidinobutane), a precursor for polyamine biosynthesis, has been identified as an important neuromodulator with anticonvulsant, antineurotoxic and antidepressant actions in the brain. In this context it has emerged as an important mediator of addiction/satiety pathways associated with alcohol misuse. Consequently, the regulation of the activity of key enzymes in agmatine metabolism is an attractive strategy to combat alcoholism and related addiction disorders. Agmatine results from the decarboxylation of L-arginine in a reaction catalyzed by arginine decarboxylase (ADC), and can be converted to either guanidine butyraldehyde by diamine oxidase (DAO) or putrescine and urea by the enzyme agmatinase (AGM) or the more recently identified AGM-like protein (ALP). In rat brain, agmatine, AGM and ALP are predominantly localised in areas associated with roles in appetitive and craving (drug-reinstatement) behaviors. Thus, inhibitors of AGM or ALP are promising agents for the treatment of addictions. In this review, the properties of DAO, AGM and ALP are discussed with a view to their role in the agmatine metabolism in mammals.


Biochimie | 2015

Mutagenic and kinetic support for an allosteric site in arginase from the extreme thermophile Bacillus caldovelox, which allows activation by arginine.

David García; Elena Uribe; Magdiel Salgado; María Paz Martínez; Nelson Carvajal

To substantiate the functionality of a crystallographically evidenced allosteric site in Bacillus caldovelox arginase (Bewley et al., 1999), we have examined the kinetic consequences of the single mutations of Asp199 and Glu256, which interact with l-arginine in this site. The introduced mutations (Asp199 → Asn, Asp199 → Ala, Glu256 → Gln and Glu256 → Ala) had no effect on the hexameric structure of the enzyme (mol. wt. 195 ± 10 kDa). However, in contrast with the Michaelis-Menten kinetics exhibited by the wild-type species, the D199A, D199N, E256A and E256Q variants exhibited positive cooperativity with respect to l-arginine. The Glu278 → Ala mutation, which compromise interactions at the trimer-trimer interface, yielded trimeric species (mol. wt. 100 ± 5 kDa) exhibiting hyperbolic kinetics that changed to sigmoidal by the additional Glu256 → Ala mutation. In addition to demonstrating the total functionality of the trimer, our results also suggest that B. caldovelox is kinetically cooperative and that the commonly detected hyperbolic behavior results from binding of l-arginine as a typical allosteric activator.


ROC Máquina: Piedras naturales, maquinaria y equipos | 2010

Travertinos: del Imperio Romano al siglo XXI: del Teatro Romano de Carthago Nova al aeropuerto de El Prat

María Ángeles García del Cura; David García; Javier Martínez Martínez; Nora Cueto Mendoza; M.A. Rodrígueza García


Investigación e Innovación Educativa en Docencia Universitaria: Retos, Propuestas y Acciones, 2016, ISBN 978-84-617-5129-7, págs. 2150-2164 | 2016

Métodos y técnicas de análisis de materiales geológicos: materiales docentes en el Grado en Geología

David García; Javier Martínez Martínez; Concepción Pla Bru; Jaime Cuevas González; María Concepción Muñoz Cervera; Juan C. Cañaveras Jiménez; Salvador Ordóñez Delgado


Clín. méd. H.C.C | 2003

Acido elaidico y lipoproteínas en pacientes con infarto al miocardio

María Leal; David García; Marvin Alvarado; María Ángeles García; Jocelyn Angulo; Marysabel Torres; Rosalía Sutil; Mariaesther Gómez; Marielena Muñoz


Clín. méd. H.C.C | 2002

Influencia de dietas saturadas y poliinsaturadas en el perfil de ácidos grasos en aorta de conejos Nueva Zelanda

David García; María Oliveros; María Leal; María de los Angeles García

Collaboration


Dive into the David García's collaboration.

Top Co-Authors

Avatar

Gerhard Schenk

University of Queensland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

María Ángeles García

National University of Distance Education

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Liam A. Wilson

University of Queensland

View shared research outputs
Top Co-Authors

Avatar

P. R. Dodd

University of Queensland

View shared research outputs
Top Co-Authors

Avatar

Mónica Salas

Austral University of Chile

View shared research outputs
Researchain Logo
Decentralizing Knowledge